Mantle Cell Lymphoma | Tumor

CURE’s mantle cell lymphoma (MCL) page features the latest cancer news and updates on mantle cell lymphoma Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in mantle cell lymphoma.

Managing Mantle Cell Lymphoma (MCL) after Relapsed on First Treatment

An interview with Dr. Luhua (Michael) Wang, MD, Department of Lymphoma and Myeloma, Division of Cancer Medicine, MD Anderson Cancer Center

Keep Inspiring

Don’t let your disease define you

Patients with MCL Who Exhausted Treatment Options Have a Potential New Therapy

January 6th 2020, 9:00pm

Article

Treatment with a CAR-T cell therapy showed promise in patients with mantle cell lymphoma, potentially leading to a new option for a group of individuals who have exhausted other options.

CAR-T Cell Therapies Could Change the Mantle Cell Lymphoma Landscape

December 14th 2019, 3:00am

Article

However, the recent addition of new chemotherapy-free options such as chimeric antigen receptor (CAR)-T cell therapy could offer hope for patients with mantle cell lymphoma who develop resistance to chemotherapy-based treatment.

BTK Inhibitors Could Replace Chemotherapy in Mantle Cell Lymphoma Treatment

December 13th 2019, 1:38am

Article

While chemotherapy is widely used in the frontline treatment of mantle cell lymphoma (MCL), earlier use of BTK inhibitors such as Imbruvica (ibrutinib) may soon make chemotherapy obsolete for some patients, according to new data presented at the 2019 American Society of Hematology (ASH) Annual Meeting.

What Patients With Mantle Cell Lymphoma Should Know About the FDA's Approval of Brukinsa

November 21st 2019, 1:00am

Article

The Food and Drug Administration approved Brukinsa to treat relapsed and refractory mantle cell lymphoma, but what does this mean for patients?

Precision Medicine and Personalized Treatments Shifting the Tide in Mantle Cell Lymphoma

November 18th 2019, 9:00pm

Article

While resistance can often make it a challenge to treat mantle cell lymphoma, therapies have come a long way in recent years thanks to the emergence of personalized treatment and the use of BTK inhibitors, according to one expert.

Promising Early Clinical Trial Results Prompt Study Expansion to Include Patients with Mantle Cell Lymphoma

November 18th 2019, 7:00pm

Article

Researchers are expanding a clinical trial to include more patients with mantle cell lymphoma after some patients given the combination of medications under investigation showed no signs of cancer after treatment.

FDA Approves Brukinsa for Patients with Relapsed and Refractory Mantle Cell Lymphoma

November 15th 2019, 8:09pm

Article

The Food and Drug Administration has approved Brukinsa to treat patients with mantle cell lymphoma whose disease has stopped responding to other medications or has recurred.

In Memoriam: Dr. Thomas Weber

September 18th 2019, 12:16am

Article

Dr. Thomas Weber has died following a ‘short but fierce’ fight with mantle cell lymphoma.

Thousands Celebrate Cancer Survivorship at Annual Life and Liberty Event

September 16th 2019, 7:18pm

Article

Patients and survivors shared messages of hope and enjoyed an evening of fun at the 11th annual celebration sponsored by Hackensack Meridian Health.

Family History Raises Risk of Blood Cancer

September 16th 2019, 6:00pm

Article

Having a parent, sibling or child with blood cancer raises an individual’s risk of also receiving a blood cancer diagnosis, according to the results of a large European study.